![]() AstraZeneca's new lab to host key research workPublished on Fri, Mar 23, 2007 at 08:37 | Source : Moneycontrol.com Updated at Fri, Mar 23, 2007 at 17:01
Bangalore March 22 AstraZeneca 's newly commissioned process R&D laboratory in Bangalore will play a key role in the development of its new drug portfolio, in particular the tuberculosis drug coming out of India, according to its top officials. The PR&D lab built at $ 15 million was launched by the company CEO, Mr David Brennan, on Wednesday; it is the fourth such for the company and the first outside Europe; two are in the UK and one in Sweden.
Dr Jan Lundberg, Executive Vice-President, Discovery Research, said, "This investment is not the end." Dr David Haywood, Global Vice-President, Global Process R&D, said the Bangalore group could later develop outsourcing capabilities for large-scale laboratory work in India. According to Dr Sudhir Nambiar, Director of the new lab, it will train pharma-biotech students in process safety. contd on page 2...
PREVIOUS STORY Trending NewsBusiness News
|
NewsVideos
Interviews
![]() May 27 2012, 11:00 | Source: CNBC-TV18 ![]() May 25 2012, 22:00 | Source: CNBC-TV18 ![]() Subscribe to Moneycontrol Newsletters |
|||||||